About Myla Lai-Goldman
Myla Lai-Goldman is a director at GeneCentric Therapeutics.
Myla Lai-Goldman first appears on SEC filings in 2011.
Experience
This experience comes from SEC filings. The years are when the filings name Myla Lai-Goldman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Myla Lai-Goldman works with at each company, as listed on that company's latest Form D.
GeneCentric Therapeutics, Inc. · Form D, Jun 20, 2025
CT
Clay Thorp
Director
MM
Michael Milburn
Executive officer and director
AL
Arnold Levine
Director
CP
Charles Perou
Director
PR
Prasanth Reddy
Director
DH
Don Hardison
Director